News from depomed, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 19, 2015, 17:35 ET

Depomed's Board of Directors Unanimously Rejects Revised Proposal from Horizon Pharma plc

 Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today announced that its Board of Directors, after careful consideration...

Aug 13, 2015, 14:01 ET

Depomed Comments on Horizon Pharma plc Letter

Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") commented on the letter sent today by Horizon Pharma plc (NASDAQ: HZNP)...

Aug 07, 2015, 06:30 ET

Depomed Sends Letter to Horizon Pharma

Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today announced that it has sent the following letter to Horizon Pharma plc (NASDAQ:...

Aug 03, 2015, 10:10 ET

Depomed Comments on Horizon Pharma Announcement

 Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today commented on Horizon Pharma plc's (NASDAQ: HZNP) ("Horizon") announcement that...

Jul 29, 2015, 16:04 ET

Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance

 Depomed, Inc. (Nasdaq: DEPO) today reported financial results and highlighted operational achievements for the quarter ended June 30,...

Jul 29, 2015, 16:03 ET

Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc

 Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today announced that its Board of Directors, after careful consideration and...

Jul 29, 2015, 08:00 ET

Depomed to Report Second Quarter Fiscal Year 2015 Financial Results on Wednesday, July 29, 2015

 Depomed, Inc. (NASDAQ: DEPO) today announced that it will release second quarter fiscal year 2015 financial results...

Jul 21, 2015, 11:23 ET

Depomed Confirms Receipt of Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc

 Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today confirmed that it has received a purported revised, highly...

Jul 08, 2015, 16:53 ET

Depomed Announces Decision in Inter Partes Review Proceeding against Purdue Pharma Confirming Patentability of All Challenged Claims

 Depomed, Inc. (Nasdaq: DEPO) today announced the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office issued...

Jul 07, 2015, 10:30 ET

Depomed Confirms Receipt of Unsolicited Proposal from Horizon Pharma plc

 Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today confirmed that it has received an unsolicited, highly conditional, non-binding...

Jun 17, 2015, 16:05 ET

Depomed Announces Change To Presentation Time At JMP Life Sciences Conference

Depomed, Inc. (NASDAQ: DEPO) today announced that the date and time of its presentation at the  2015 JMP Securities Life Sciences Conference...

Jun 03, 2015, 08:00 ET

Depomed Announces Zipsor® ANDA Litigation Settlement Providing for Exclusivity to March 2022

Depomed, Inc. (Nasdaq: DEPO) today announced it has entered into a settlement agreement in its ongoing patent litigation related to an Abbreviated...

May 26, 2015, 16:01 ET

Depomed To Present At Healthcare Conferences In June

Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at two healthcare conferences in June. The 2015 Jefferies Healthcare...

May 13, 2015, 16:01 ET

Depomed To Present At Healthcare Conferences In May

 Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at two healthcare conferences in May. The 2015 Bank of America...

May 11, 2015, 16:05 ET

Depomed Reports First Quarter 2015 Financial Results

Depomed, Inc. (Nasdaq: DEPO) today reported financial results and highlighted operational achievements for the quarter ended March 31,...

Apr 30, 2015, 08:00 ET

Depomed to Report First Quarter Fiscal Year 2015 Financial Results on Monday, May 11, 2015

 Depomed, Inc. (NASDAQ:DEPO) today announced that it will release first quarter fiscal year 2015 financial results after the market closes...

Apr 13, 2015, 08:00 ET

Depomed Announces Gralise® ANDA Litigation Settlement Confirming Exclusivity to 2024 and Dismissing Appeal

Depomed, Inc. (Nasdaq: DEPO) today announced it has entered into a settlement agreement with Actavis, Inc. in Depomed's patent infringement...

Apr 02, 2015, 16:05 ET
Mar 17, 2015, 08:32 ET

Depomed Announces Termination of Hart-Scott-Rodino Waiting Period for Pending Acquisition of NUCYNTA® Franchise from Janssen Pharmaceuticals

 Depomed, Inc. (Nasdaq: DEPO), today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act)...

Mar 12, 2015, 16:05 ET

Depomed Secures $575 Million Debt Facility From Deerfield and Pharmakon to Finance the Closing of NUCYNTA® Acquisition

Depomed, Inc. (NASDAQ: DEPO) today announced that it has entered into a definitive agreement with Deerfield and Pharmakon Advisors, LP to...